Comparison of outcomes and costs of extracorporeal blood purification therapies in critically ill COVID‐19 patients
Sign Up to like & getrecommendations! Published in 2022 at "Therapeutic Apheresis and Dialysis"
DOI: 10.1111/1744-9987.13948
Abstract: Plasmapheresis and hemoperfusion are used against cytokine release syndrome in COVID‐19. This study aims to compare their outcomes, costs, and side‐effects. read more here.
Keywords: comparison outcomes; costs extracorporeal; purification therapies; extracorporeal blood ... See more keywords